Eurofins Genomics Extremers

Eurofins Genomics has launched its Extremer line of "extremely long" oligonucleotides in the US.

The company developed the oligos on its new DNA synthesis platform using high-fidelity chemistry for synthetic biology, next-generation DNA sequencing, and other applications.

Specific uses might include constructing genes with low sequence variability segments; templating in vitro transcription of RNA molecules; introducing large-scale or multi-site mutations; and generating oligos for DNA-directed RNA interference, capture probes, or qPCR control standards.